Status:
NOT_YET_RECRUITING
Evaluate the Incidence of Junctional Rhythms Occurring During Post-procedure TAVI Hospitalization.
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Incidence of Junctional Rhythm
Eligibility:
All Genders
18+ years
Brief Summary
Transcatheter Aortic Valve Implantation (TAVI) aims to treat patients with symptomatic narrowing of the aorta by implanting an aortic bioprosthesis. This technique, which is currently highly developed...
Detailed Description
Monocentric observational study including all patients implanted with aortic bioprosthesis \[undergoing Transcatheter Aortic Valve Implantation (TAVI)\] at Clermont-Ferrand University Hospital, betwee...
Eligibility Criteria
Inclusion
- Major patients who have undergone or are undergoing a TAVI procedure (since 01/12/2023) and who present a junctional rhythm.
Exclusion
- Minor patients
- Patients already implanted with a pacemaker
- Atrial fibrillation
- Pregnant women.
- Patients under guardianship or legal protection
- Patients deprived of liberty
- Patients refusing to participate in the study
Key Trial Info
Start Date :
October 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06599008
Start Date
October 5 2024
End Date
May 1 2025
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, France, 63000
2
CHU clermont-Ferrand
Clermont-Ferrand, France